Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash	$ 88,022	$ 86,128
Restricted cash	20,000	20,000
Accounts receivable	18,976	18,976
Prepaid & other current assets	10,594	9,107
Total current assets	137,592	134,211
In process R&D	1,101,760	1,101,760
Goodwill, net of impairment	2,788,230	2,788,230
Investment in GMP Bio at fair value	22,653,225	22,653,225
Total assets	26,680,807	26,677,426
Current liabilities:
Accounts payable and accrued liabilities	2,487,234	2,437,167
Contingent consideration	2,625,000	2,625,000
Derivative liability on notes	278,786	703,616
Total current liabilities	19,286,912	19,199,914
Total liabilities	19,286,912	19,199,914
Commitments and contingencies (Note 13)
Stockholders’ equity:
Common stock, $.01 par value; 750,000,000 shares authorized; 408,292,720 and 407,289,888 issued and outstanding, respectively	4,082,927	4,072,899
Additional paid-in capital	42,279,570	42,219,400
Accumulated deficit	(38,061,528)	(38,040,668)
Total Oncotelic Therapeutics, Inc. stockholders’ equity	8,300,969	8,251,631
Non-controlling interests	(907,074)	(774,119)
Total stockholders’ equity	7,393,895	7,477,512
Total liabilities and stockholders’ equity	26,680,807	26,677,426
Related Party [Member]
Current liabilities:
Accounts payable to related party	347,084	346,057
Convertible debt	3,608,634	3,297,208
Nonrelated Party [Member]
Current liabilities:
Convertible debt	$ 9,940,174	$ 9,790,866

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).